Zoledronic acid


( Last Updated : November 29, 2007)
Generic Name:
Zoledronic acid
Project Status:
Complete
Therapeutic Area:
Osteoporosis, postmenopausal women
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Aclasta
Project Line:
Reimbursement Review
Project Number:
SR0114-000

Details


Submission Type:
Initial
Indications:
Osteoporosis, postmenopausal women
Recommendation Type:
Do not list
Final Recommendation: